All three medications influence appetite and metabolism, but they do it in slightly different ways
The coveted injectable a form of the glucose-regulating drug semaglutide, which boasts weight loss as a (wildly lucrative) side effect is technically FDA-approved for those with Type 2 diabetes (and, at a higher dose, obesity), yet its now being used by a vast collective of folks solely for aesthetic purposes
Tirzepatide is a medication used primarily for the treatment of type 2 diabetes and for weight loss in individuals with or without diabetes
However, achieving prediabetes remission, that is, reaching normal glucose regulation according to American Diabetes Association criteria, is more efficient in preventing T2D than solely reaching weight loss goals
Retrieved from Ding, C., Lim, L